This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Expanding the armamentarium for the spondyloarthropathies
Arthritis Res Ther 2004, 6(Suppl 2):S36-S43 doi:10.1186/ar1012
No comments have yet been made on this article.
